Domov › Rak pljuč › Connecticut › Stamford
Klinične študije za Rak pljuč v Stamford, CT
10 študij za Rak pljuč išče udeležence na lokacijah v Stamford in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi stran
- Good Samaritan University Hospital, West Islip · 27 mi stran
- Northwell Health Imbert Cancer Center, Bay Shore · 27 mi stran
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Vključevanje udeležencevFaza 3
- Stamford Hospital/Bennett Cancer Center, Stamford
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Vključevanje udeležencevFaza 3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Stamford Hospital/Bennett Cancer Center, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi stran
- in še 1
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Vključevanje udeležencevFaza 3
- Stamford Hospital ( Site 0083), Stamford
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mi stran
- Northwell Health Imbert Cancer Center, Bay Shore · 27 mi stran
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi stran
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi stran
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Vključevanje udeležencevOpazovalna študija
- Stamford Hospital, Stamford
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Vključevanje udeležencevOpazovalna študija
- The Stamford Health/The Stamford Hospital, Stamford
- Good Samaritan Cancer Center, West Islip · 27 mi stran
Študije za Rak pljuč v drugih mestih
- Houston, TX78 študij
- Boston, MA62 študij
- New York City, NY60 študij
- Los Angeles, CA45 študij
- Washington, DC41 študij
- Arlington, VA41 študij
- Chicago, IL41 študij
- Nashville, TN40 študij
- Baltimore, MD40 študij
- St. Louis, MO39 študij
- Columbus, OH37 študij
- Philadelphia, PA36 študij
Druge študije v Stamford
- Rak dojke9 študij
- Nemalicelični pljučni rak8 študij
- Migrena6 študij
- Debelost6 študij
- Rak prostate5 študij
- Rak jajčnikov5 študij
- Prekomerna telesna teža4 študij
- Rak trebušne slinavke4 študij
- Srčno-žilne bolezni4 študij
- Nevrološke bolezni3 študij
- Atrijska fibrilacija3 študij
- Metastatski rak3 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.